多发性硬化
髓鞘
兰维尔结
轴突
神经科学
脑脊髓炎
实验性自身免疫性脑脊髓炎
小胶质细胞
生物
病理
再髓鞘化
中枢神经系统
炎症
免疫学
医学
作者
Kareem C. Clark,Anna Josephson,Savannah D. Benusa,Rebecca K. Hartley,Matthew Baer,Suneel K Thummala,Martha Joslyn,Brooke A. Sword,Howard L. Elford,Unsong Oh,Aysegul Dilsizoglu‐Senol,Catherine Lubetzki,Marc Davenne,George H. DeVries,Jeffrey L. Dupree
出处
期刊:Glia
[Wiley]
日期:2016-04-21
卷期号:64 (7): 1190-1209
被引量:52
摘要
Axonal pathology is a key contributor to long‐term disability in multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS), but the mechanisms that underlie axonal pathology in MS remain elusive. Evidence suggests that axonal pathology is a direct consequence of demyelination, as we and others have shown that the node of Ranvier disassembles following loss of myelin. In contrast to the node of Ranvier, we now show that the axon initial segment (AIS), the axonal domain responsible for action potential initiation, remains intact following cuprizone‐induced cortical demyelination. Instead, we find that the AIS is disrupted in the neocortex of mice that develop experimental autoimmune encephalomyelitis (EAE) independent of local demyelination. EAE‐induced mice demonstrate profound compromise of AIS integrity with a progressive disruption that corresponds to EAE clinical disease severity and duration, in addition to cortical microglial reactivity. Furthermore, treatment with the drug didox results in attenuation of AIS pathology concomitantly with microglial reversion to a less reactive state. Together, our findings suggest that inflammation, but not demyelination, disrupts AIS integrity and that therapeutic intervention may protect and reverse this pathology. GLIA 2016;64:1190–1209
科研通智能强力驱动
Strongly Powered by AbleSci AI